Study analysis · Journal of Clinical Medicine · 2024
Your heart's fat might be secretly triggering your irregular heartbeat — and doctors never checked it before.
People with irregular heartbeats have 40% more inflammation in the fat around their main heart artery, even when their arteries aren't clogged.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study looked at people who already had heart scans and found that those with AF had more inflammation around their heart arteries. But it didn't watch them over time to see if the inflammation came first or if AF caused the inflammation — so we can't say one causes the other, just that they often happen together.
What’s the bottom line?
Around the heart's arteries, there's a layer of fat. When it gets inflamed, it can send signals that mess with the heart's rhythm. This study looked at people with and without a common heart rhythm problem called atrial fibrillation.
How strong is this study?
The study used fancy computer tools to measure inflammation accurately, which is good. But it only looked at people from one hospital who were already getting scanned for chest pain, so it doesn't tell us much about most people with AF. That makes the results less trustworthy for everyone else.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
27 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=81)+6.7/20
- Follow-upno follow-up reported
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 544 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
This design cannot establish causation — the findings describe an association, not a cause. This is an observational cross-sectional study with no randomization or temporal sequencing to determine if inflammation preceded AF or resulted from it. Confounding factors (e.g., shared risk factors like age, CAD) cannot be ruled out.
Moderate COI
Moderate conflicts that may influence study outcomes
The study used a third-party company (Caristo Diagnostics) for AI-based image analysis, but no funding source or author affiliations with the company are disclosed, raising concerns about potential undisclosed industry influence.
Conflict Details
Caristo Diagnostics Center: CCTA images were sent to Caristo Diagnostics for FAI Score analysis using AI algorithms, and results were returned for further analysis; no disclosure of funding or employment relationship provided.
The use of a commercial AI analysis platform (Caristo Diagnostics) without disclosure of funding, author affiliations, or contractual relationships introduces a significant risk of undisclosed bias. While the company appears to have performed only image analysis, the lack of transparency about funding or potential industry ties constitutes a moderate conflict of interest. No independent validation or oversight of the AI analysis is mentioned.
Key takeaways
- 01
People with atrial fibrillation had 40% higher inflammation in the fat around their main left heart artery (15.5 vs.
- 02
11.1 on a special scale), even when their artery blockages were similar.
- 03
Yes—this suggests that inflammation in the heart's fat, not just clogged arteries, might be a hidden trigger for irregular heartbeats.
Surprising findings
- Patients without AF had significantly higher coronary calcium scores (472.2 vs. 231.7) and more severe artery blockages in the LCX and RCA.You’d expect AF patients to have worse atherosclerosis — but the opposite was true. This flips the script: AF may be driven by inflammation, not plaque.
- There was no difference in standard blood markers like CRP, cholesterol, or white blood cell count between AF and non-AF patients.Systemic inflammation didn’t show up in blood tests — yet local fat inflammation did. This means AF risk might be invisible to traditional labs.
Practical takeaways
If you're getting a CCTA scan for chest pain, ask if they're calculating the FAI Score — it might reveal hidden AF risk.
This study was small (n=81), single-center, and observational — it doesn't prove FAI Score can predict future AF, only that it's linked to existing AF.
medium confidenceWhy this study matters
Inflammation in Fat, Not Just Clogged Arteries
Patients with atrial fibrillation (AF) had a mean FAI Score of 15.53 vs. 11.09 in those without AF — a 40% difference — even when their coronary stenosis and calcium scores were similar or lower. This suggests AF isn't just about blockages; it's tied to invisible fat inflammation.
Most people think heart rhythm problems come from clogged arteries, but this shows inflammation in surrounding fat — something invisible on regular scans — could be the real trigger.
Left Side Focus: Why the Left Artery Matters
The inflammation difference was strongest in the left anterior descending artery (LAD): 13.17 vs. 8.80 FAI Score. This is the same artery that feeds the left atrium — where AF usually starts.
It suggests the heart’s rhythm disorder might be sparked by localized inflammation right next to the chamber that misfires — like a fire starting exactly where the fuse is.
The FAI Score: A New Hidden Biomarker
The FAI Score — an AI-calculated measure of fat inflammation from standard CCTA scans — was significantly higher in AF patients (p=0.0007) and independent of age, BMI, cholesterol, or calcium burden.
This could mean your next heart scan might reveal AF risk you didn’t know you had — without blood tests or invasive procedures.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Around the heart's arteries, there's a layer of fat. When it gets inflamed, it can send signals that mess with the heart's rhythm. This study looked at people with and without a common heart rhythm problem called atrial fibrillation.
Research results
People with atrial fibrillation had 40% higher inflammation in the fat around their main left heart artery (15.5 vs. 11.1 on a special scale), even when their artery blockages were similar.
What this means - more context
Yes—this suggests that inflammation in the heart's fat, not just clogged arteries, might be a hidden trigger for irregular heartbeats.
This study investigates whether pericoronary fat inflammation, measured by the FAI Score via CCTA, is associated with atrial fibrillation (AF) in patients with coronary artery disease.
Patients with AF showed significantly higher FAI Scores than those without AF, particularly around the left anterior descending artery, independent of coronary stenosis severity or calcium burden. Left atrial enlargement was also confirmed in AF patients.
Methods Used
Retrospective cross-sectional study of 81 patients (36 with AF, 45 without) undergoing 128-slice CCTA. FAI Score—a CCTA-derived biomarker adjusted for age and sex—was computed using AI-assisted analysis (Caristo Diagnostics) to quantify pericoronary fat inflammation.
Main Finding
The mean FAI Score was significantly higher in AF patients (15.53 ± 10.29 vs. 11.09 ± 6.70, p = 0.0007), with the greatest difference observed in the left anterior descending artery (13.17 ± 7.91 vs. 8.80 ± 4.75, p = 0.008), independent of traditional atherosclerosis markers.
Confidence Level
Moderate. Findings are statistically significant but limited by small sample size, single-center design, lack of randomization, and absence of serum inflammatory biomarkers or long-term outcomes.
Study Flags
Red Flags
- •Small sample size (n=81)
- •Single-center, retrospective design
- •No serum inflammatory biomarkers or long-term follow-up
Surprising Findings
Patients without AF had significantly higher coronary calcium scores (472.2 vs. 231.7) and more severe artery blockages in the LCX and RCA.
You’d expect AF patients to have worse atherosclerosis — but the opposite was true. This flips the script: AF may be driven by inflammation, not plaque.
Practical Takeaways
If you're getting a CCTA scan for chest pain, ask if they're calculating the FAI Score — it might reveal hidden AF risk.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 544 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Human Cross-Sectional
Subject
Moderate probability
on the GRADE evidence scale
This study looked at people who already had heart scans and found that those with AF had more inflammation around their heart arteries. But it didn't watch them over time to see if the inflammation came first or if AF caused the inflammation — so we can't say one causes the other, just that they often happen together.
Moderate conflicts detected — such as industry funding with partial involvement. A meaningful penalty has been applied.
Strengths
- Use of standardized, validated imaging biomarker (FAI Score) for pericoronary inflammation
- Objective, quantitative imaging analysis using AI-assisted technology
- Adjustment for key confounders like age, sex, and coronary stenosis severity
Weaknesses
- Cross-sectional design prevents determination of temporal sequence
- No control for unmeasured confounders (e.g., diet, physical activity, serum biomarkers)
- Small sample size limits statistical power and subgroup analyses
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Around the heart's arteries, there's a layer of fat. When it gets inflamed, it can send signals that mess with the heart's rhythm. This study looked at people with and without a common heart rhythm problem called atrial fibrillation.
Research results
People with atrial fibrillation had 40% higher inflammation in the fat around their main left heart artery (15.5 vs. 11.1 on a special scale), even when their artery blockages were similar.
What this means - more context
Yes—this suggests that inflammation in the heart's fat, not just clogged arteries, might be a hidden trigger for irregular heartbeats.
This study investigates whether pericoronary fat inflammation, measured by the FAI Score via CCTA, is associated with atrial fibrillation (AF) in patients with coronary artery disease.
Patients with AF showed significantly higher FAI Scores than those without AF, particularly around the left anterior descending artery, independent of coronary stenosis severity or calcium burden. Left atrial enlargement was also confirmed in AF patients.
Methods Used
Retrospective cross-sectional study of 81 patients (36 with AF, 45 without) undergoing 128-slice CCTA. FAI Score—a CCTA-derived biomarker adjusted for age and sex—was computed using AI-assisted analysis (Caristo Diagnostics) to quantify pericoronary fat inflammation.
Main Finding
The mean FAI Score was significantly higher in AF patients (15.53 ± 10.29 vs. 11.09 ± 6.70, p = 0.0007), with the greatest difference observed in the left anterior descending artery (13.17 ± 7.91 vs. 8.80 ± 4.75, p = 0.008), independent of traditional atherosclerosis markers.
Confidence Level
Moderate. Findings are statistically significant but limited by small sample size, single-center design, lack of randomization, and absence of serum inflammatory biomarkers or long-term outcomes.
Study Flags
Red Flags
- •Small sample size (n=81)
- •Single-center, retrospective design
- •No serum inflammatory biomarkers or long-term follow-up
Surprising Findings
Patients without AF had significantly higher coronary calcium scores (472.2 vs. 231.7) and more severe artery blockages in the LCX and RCA.
You’d expect AF patients to have worse atherosclerosis — but the opposite was true. This flips the script: AF may be driven by inflammation, not plaque.
Practical Takeaways
If you're getting a CCTA scan for chest pain, ask if they're calculating the FAI Score — it might reveal hidden AF risk.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 544 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Human Cross-Sectional
Subject
Moderate probability
on the GRADE evidence scale
This study looked at people who already had heart scans and found that those with AF had more inflammation around their heart arteries. But it didn't watch them over time to see if the inflammation came first or if AF caused the inflammation — so we can't say one causes the other, just that they often happen together.
Moderate conflicts detected — such as industry funding with partial involvement. A meaningful penalty has been applied.
Strengths
- Use of standardized, validated imaging biomarker (FAI Score) for pericoronary inflammation
- Objective, quantitative imaging analysis using AI-assisted technology
- Adjustment for key confounders like age, sex, and coronary stenosis severity
Weaknesses
- Cross-sectional design prevents determination of temporal sequence
- No control for unmeasured confounders (e.g., diet, physical activity, serum biomarkers)
- Small sample size limits statistical power and subgroup analyses
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
The study used fancy computer tools to measure inflammation accurately, which is good. But it only looked at people from one hospital who were already getting scanned for chest pain, so it doesn't tell us much about most people with AF. That makes the results less trustworthy for everyone else.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
27 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=81)+6.7/20
- Follow-upno follow-up reported
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 544 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
This design cannot establish causation — the findings describe an association, not a cause. This is an observational cross-sectional study with no randomization or temporal sequencing to determine if inflammation preceded AF or resulted from it. Confounding factors (e.g., shared risk factors like age, CAD) cannot be ruled out.
Moderate COI
Moderate conflicts that may influence study outcomes
The study used a third-party company (Caristo Diagnostics) for AI-based image analysis, but no funding source or author affiliations with the company are disclosed, raising concerns about potential undisclosed industry influence.
Conflict Details
Caristo Diagnostics Center: CCTA images were sent to Caristo Diagnostics for FAI Score analysis using AI algorithms, and results were returned for further analysis; no disclosure of funding or employment relationship provided.
The use of a commercial AI analysis platform (Caristo Diagnostics) without disclosure of funding, author affiliations, or contractual relationships introduces a significant risk of undisclosed bias. While the company appears to have performed only image analysis, the lack of transparency about funding or potential industry ties constitutes a moderate conflict of interest. No independent validation or oversight of the AI analysis is mentioned.
Standing
Who’s using this study?
The videos and claims on this site that lean on this study, and the researchers who wrote it.
1 video from Dr Brad Stanfield cite this study, drawing 1 claim from it.
- Strong evidence
At least some randomized or controlled trials support this claim.
Evidence
Authored by
13 researchersIf this is your work, this is how we attribute it on Fit Body Science. Renáta Gerculy is listed as the lead author.
- Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș
Cited in 2 claims
- Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș
Cited in 1 claim
- Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș
Cited in 2 claims
- Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș
Cited in 3 claims
- Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș
Cited in 3 claims